- Bird Flu Virus in Canadian Teen Shows Mutations That Could Help It Spread Among Humans
- Flu, COVID Vaccination Rates Remain Low as Winter Nears
- ’10 Americas:’ Health Disparities Mean Life Expectancy Varies Across U.S.
- Short-Term Hormone Therapy for Menopause Won’t Harm Women’s Brains
- Could a Vitamin Be Effective Treatment for COPD?
- Woman Receives World’s First Robotic Double-Lung Transplant
- Flavored Vapes Behind Big Surge in U.S. E-Cigarette Sales
- Reading Beyond Headline Rare For Most on Social Media, Study Finds
- Meds Like Ozempic Are Causing Folks to Waste More Food
- Fibroids, Endometriosis Linked to Shorter Life Spans
Can HIV Drugs Boost Syphilis Risk?
Gay and bisexual men taking antiretroviral drugs to treat HIV infection may be at increased risk for syphilis, new research contends.
Based on a review of available evidence, the investigators concluded that the drugs may boost susceptibility to the bacterium that causes syphilis, although the study did not prove cause-and-effect.
The finding might explain why new and repeat cases of syphilis in gay and bisexual men have risen sharply compared to other sexually transmitted infections over the past decade, the researchers wrote.
The study team was led by Dr. Michael Rekart, from the University of British Columbia’s School of Population and Public Health in Vancouver. The findings were published in the Jan. 16 issue of the journal Sexually Transmitted Infections.
The authors of an editorial that accompanied the study said the theory is “intriguing” and “warrants careful consideration.” But the editorial also suggested that the increase in syphilis cases among gay and bisexual men may be due to other factors.
“We are living in an era where [antiretroviral therapy] is being used to effectively treat and prevent HIV infection. To some extent this seems to have tempered the urgency to control other [sexually transmitted infections]. As history has shown many times over, that would be a costly mistake,” said Susan Tuddenham, Maunank Shah and Khalil Ghanem, from Johns Hopkins University School of Medicine in Baltimore.
“Over the past 15 years, syphilis rates among [gay and bisexual men] have been rising unabated,” Tuddenham and colleagues noted in a journal news release.
“If further investigations support a role for [antiretroviral therapy] in increasing susceptibility to syphilis, this will provide one more reason why screening, diagnosis and treatment of [sexually transmitted infections] in [gay and bisexual men] must be prioritized,” the editorial concluded.
More information
The U.S. National Institute of Allergy and Infectious Diseases has more on syphilis.
Source: HealthDay
Copyright © 2024 HealthDay. All rights reserved.